Travere Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 7.87 M | $300.69 M | -2.85% | 8.82% |
| VANGUARD GROUP INC | 01/29/2026 | 6.31 M | $241.08 B | -4.60% | 7.07% |
| STATE STREET CORP | 02/13/2026 | 4.76 M | $181.75 M | 47.82% | 5.33% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 3.77 M | $144.19 B | 100.00% | 4.23% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 3.76 M | $143.82 M | -44.02% | 4.22% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.25 M | $85.85 M | 28.23% | 2.52% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.14 M | $81.92 B | 0.26% | 2.40% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 1.87 M | $71.38 B | 46.65% | 2.09% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.85 M | $70.70 B | 32.27% | 2.07% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 02/05/2026 | 1.72 M | $65.78 M | 7.62% | 1.93% |
| EMERALD ADVISERS, LLC | 02/09/2026 | 1.59 M | $60.91 M | -25.74% | 1.79% |
| MORGAN STANLEY | 02/13/2026 | 1.42 M | $54.10 M | 26.75% | 1.59% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.16 M | $44.20 M | 24.52% | 1.30% |
| NUVEEN, LLC | 02/12/2026 | 993.61 K | $37.97 M | -7.89% | 1.11% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/09/2026 | 948.46 K | $36.24 M | -21.02% | 1.06% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 900.30 K | $34.40 M | 184.63% | 1.01% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 881.68 K | $33.69 M | -44.87% | 0.99% |
| FIERA CAPITAL CORP | 02/11/2026 | 874.05 K | $33.40 M | 100.00% | 0.98% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 808.19 K | $30.88 M | -4.73% | 0.91% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 805.22 K | $30.77 M | -5.51% | 0.90% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 725.50 K | $27.72 M | 4.13% | 0.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 718.40 K | $27.45 M | 70.88% | 0.81% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 665.80 K | $25.44 M | 17.72% | 0.75% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 623.39 K | $23.82 M | -27.34% | 0.70% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 587.35 K | $22.44 M | 3.10% | 0.66% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 536.93 K | $20.52 M | 3.14% | 0.60% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 534.61 K | $20.78 M | -21.88% | 0.60% |
| ABRDN PLC | 01/16/2026 | 518.36 K | $19.81 M | -46.42% | 0.58% |
| CANDRIAM S.C.A. | 02/13/2026 | 468.56 K | $17.90 M | -8.61% | 0.53% |
| UBS GROUP AG | 01/29/2026 | 422.62 K | $16.15 M | -14.29% | 0.47% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 417.74 K | $15.96 M | 347.48% | 0.47% |
| JANE STREET GROUP, LLC | 02/12/2026 | 392.27 K | $14.99 B | 100.00% | 0.44% |
| BARCLAYS PLC | 02/13/2026 | 369.53 K | $14.12 M | 5.88% | 0.41% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 352.72 K | $13.48 M | 12.55% | 0.40% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 341.72 K | $13.06 M | 98.18% | 0.38% |
| JPMORGAN CHASE & CO | 02/11/2026 | 321.62 K | $12.29 M | -34.87% | 0.36% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 319.66 K | $12.21 M | 179.23% | 0.36% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 300.00 K | $11.46 M | -40.00% | 0.34% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 268.93 K | $10.28 M | -15.47% | 0.30% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 268.05 K | $10.24 M | -18.44% | 0.30% |
| JANE STREET GROUP, LLC | 02/12/2026 | 256.80 K | $9.81 B | -20.30% | 0.29% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 256.34 K | $9.79 M | -76.36% | 0.29% |
| NEW YORK STATE COMMON RETIREMENT FUND | 02/12/2026 | 249.56 K | $9.54 M | 797.24% | 0.28% |
| CITADEL ADVISORS LLC | 02/17/2026 | 244.10 K | $9.33 B | 35.01% | 0.27% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 241.59 K | $9.23 M | -38.38% | 0.27% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 238.92 K | $9.13 M | 100.00% | 0.27% |
| IMPAX ASSET MANAGEMENT GROUP PLC | 01/29/2026 | 225.00 K | $8.60 M | -52.63% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 220.00 K | $8.41 M | -7.27% | 0.25% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 219.75 K | $8.40 M | 59.69% | 0.25% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2026 | 218.03 K | $8.33 M | 3.00% | 0.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Travere Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 277 institutional investors and hedge funds held shares of Travere Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 7.87 M
VANGUARD GROUP INC: 6.31 M
STATE STREET CORP: 4.76 M
MACQUARIE MANAGEMENT HOLDINGS, INC.: 3.77 M
ARMISTICE CAPITAL, LLC: 3.76 M
RENAISSANCE TECHNOLOGIES LLC: 2.25 M
37.26% of Travere Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 74.01 M shares in the last 24 months. This purchase volume represents approximately $2.17 B in transactions.